Delivery Order SPE2DB20D1100-SPE2DB25FE2M5
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,276.61 on August 8, 2025, for the supply of Pediarix 0.5 ML syringes. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 11, 2025, with performance to be executed at the vendor's facility in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's broader contractual...
- The Defense Logistics Agency awarded a delivery order valued at $12,360.60 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes, a pediatric vaccine combination product. This firm fixed price delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive award under an existing contract vehicle. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $4,253.00 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Pediarix 0.5 ML syringes. This delivery order, which is not set-aside designated, represents a firm fixed price contract with an ultimate completion date of August 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Pediarix is a pediatric combination vaccine used for immunization against multiple...
- The Defense Logistics Agency awarded a delivery order valued at $40,587.48 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Pediarix 0.5 mL syringes. The contract represents a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill performance...
- The Defense Logistics Agency awarded a delivery order valued at $1,299.69 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ML syringes. The contract is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and was awarded on August 8, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,898.50 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ML syringes on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Pediarix is a combination pediatric vaccine used for immunization against multiple diseases, supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Pediarix 0.5 ML syringes with a ceiling value of $16,511.76. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 26, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. Pediarix is a pediatric combination vaccine, and this order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $5,344.50 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ML syringes. This firm fixed price contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a pediatric vaccine delivery under the agency's medical supply chain operations. The award utilizes no set-aside designation and was competitively awarded through open competition. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,373.80 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed price contract involves no set-aside designation and represents a competitive award under the company's broader pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,299.69 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Pediarix 0.5 ML syringes. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The vaccine product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, with an...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE2M5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,759.00 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ml syringes. This competitively awarded, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Pediarix is a pediatric combination vaccine, and this order represents one of numerous pharmaceutical and medical supply deliveries AmerisourceBergen fulfills through its federal contracts. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical devices to support military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains and delivery scales, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 8/25/25 |